Dexamethasone/Netilmicin Sulfate

地塞米松/硫酸奈替米星

Report date: 2023/12/30 20:00:46

Base Information

Drug NameDexamethasone/Netilmicin Sulfate
Drug Alias NameDexamethasone/netilmicinNetilmicin Sulfate/Dexamethasonedexamethasone and netilmicin sulfateNetildex
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Aminoglycoside antibioticsSmall molecules > Steroids
Mechanisms of Action30S ribosomal subunit inhibitorsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor30S ribosomal subunit
Therapy Area/IndicationsCataractMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesRomania +[11] 
CombinationsYes DexamethasoneNetilmicin Sulfate
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKnight Therapeutics (Usa) Inc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesSIFI SpA
Active IndicationsMultiple Myeloma
Inactive IndicationsCataract

Other Information

ATC CodeN/A
Related LinksN/A